Medical Giant Convatec Selects Manchester for Flagship Research Center

02-10-2025


Global medical technology company Convatec has announced plans to establish a new flagship research and development hub in Manchester as part of a £500 million investment in the United Kingdom. The FTSE100-listed firm, which specializes in products for chronic wounds, diabetes, urinary incontinence, and stomas, will relocate its R&D operations from Deeside to Bruntwood SciTech's CityLabs 4.0 facility, scheduled to open in 2027. This strategic move represents a significant commitment to the UK's life sciences sector at a time when several other pharmaceutical companies have been shifting investments overseas.

The new Manchester facility will become one of the largest centers in Convatec's global network, spanning 125,000 square feet across seven storeys in the £42 million CityLabs 4.0 building. Located on Hathersage Road facing the Manchester Royal Infirmary, St Mary's and Royal Manchester Children's Hospital, the state-of-the-art facility will focus on research in four key therapeutic areas: advanced wound care, ostomy care, continence care, and infusion care. The company cited Manchester's "vibrant life sciences ecosystem, which includes leading universities, hospitals, and research institutions" as the primary reason for selecting the location.

Approximately 200 staff will be employed at the new Manchester hub, with most positions transferring from Convatec's existing R&D operation in Deeside, North Wales, which has served as a major research center since 1996. The company emphasized that no redundancies are planned as a consequence of the relocation and that the Deeside manufacturing site will remain unaffected, continuing to employ around 400 workers. The new Manchester facility is approximately 50% larger than the current Deeside operation and has capacity for up to 250 employees, allowing for future expansion.

Convatec's investment comes as part of a broader $1 billion worldwide R&D commitment, with the UK portion representing nearly half of this global initiative. The company, which generated $2.3 billion in revenue last year, typically allocates approximately 5% of its annual revenue to research and development. The relocation to Manchester positions Convatec to leverage the city's concentration of medical research institutions, including neighboring organizations such as the University of Manchester NHS Foundation Trust, biotech company QIAGEN, and MAC Clinical Research, strengthening its pipeline of new products addressing unmet needs in chronic care.

Other news

Families Demand Inquiry Into 1994 Chinook Crash With 47,000-Signature Petition

{'$date': '2025-10-20T11:49:57.546Z'}


Families of the 29 victims killed in the 1994 Chinook helicopter crash are escalating their decades-long fight for answers, preparing to deliver a petition with more than 47,000 signatures to Downing Street demanding a public inquiry. The Chinook Justice Campaign has published 110 "critical questions" they want answered about the tragedy that claimed the lives of 25 intelligence experts and four special forces crew members when the aircraft crashed on the Mull of Kintyre on June 2, 1994.

The campaign comes after Prime Minister Sir Keir Starmer rejected calls for a judge-led inquiry into the incident, prompting families to declare they will "see the UK government in court." Among those delivering the petition on Tuesday are brothers Andy and Matt Tobias from Watford, whose father John Tobias was killed in the crash. The petition delivery will be accompanied by an attempt to deliver a letter directly to the Ministry of Defence.

Central to the families' concerns are questions about mission authorization, aircraft selection, and whether those on board were properly warned of risks. The campaign has gained momentum amid revelations that key documents related to the crash have been sealed until 2094—a century after the incident occurred. David Hill, technical expert for the Chinook Justice Campaign, characterized the government's position as "a betrayal by the state of them and their loved ones."

The crash investigation has followed a contentious path over the past three decades. Initial findings blamed pilot error for the tragedy, but this conclusion was overturned in 2011. The continuing secrecy surrounding the incident has drawn criticism from campaigners who argue it "undermines trust not only in the MoD but in the government itself." As families prepare to confront the government directly, the case represents one of Britain's longest-running military accountability battles.